Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation

NCT00765882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

633

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Constipation

Interventions

DRUG: Linaclotide 290 micrograms
DRUG: Linaclotide 145 micrograms
DRUG: Placebo

Sponsor

Forest Laboratories

Collaborators

[object Object]